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3List of abbreviations
CO2 Carbon dioxide
CSR Cold steel resection
H&E Hemalaun and eosin
HNSCC Head and neck squamous cell carcinoma
ICO:NZW Iffa Credo New Zealand White rabbits
LN(s) Lymph node(s)
LSR Laser-surgical resection
ND Neck dissection
SCC Squamous cell carcinoma
41. Introduction
Cancer of the upper aerodigestive tract presents nowadays an important medical
problem. This anatomical region is the sixth most often localisation of malignancies. In
up to 90% of all these cases the histological type is squamous cell carcinoma (SCC)
[9,40,55]. The most pronounced causative agents are the tobacco and alcohol
consumption [56,89].
An important characteristic in the natural course of head and neck SCC (HNSCC) is its
tendency to disseminate to the regional lymph nodes (LN) and on a later stage to distant
organs [84,117,119]. The presence of LN metastases plays a decisive role for the
therapeutic approach to the patient and the overall prognosis [14,91,123]. The neoplastic
dissemination of HNSCC has a quite predictable direction, determined by the lymph
drainage pathways. The lymph from every single region drains along relatively constant
collectors to only some particular LNs of the total about 300 LNs in the head and neck
[53,119]. As a result of extensive anatomic and clinical studies the LNs in the neck are
systematized in several clinico-pathologic groups, which have clearly delimitable
anatomic borders and collect the lymph from well defined areas of the mucosa
[57,90,117]. In this way to every tumor location in the upper aerodigestive tract
correspond certain regional lymph nodes that are most likely to harbour metastases from
this primary locations. Apart of this lymphatic spread tumoral cells may further
propagate from the primary site and the involved LN with the blood circulation to
distant locations (usually the lungs, liver or bones) [27,34]. From this background the
SCC of the head and neck is not just a tumor in this region, but a multilevel pathologic
process, determined by the spread from this primary locus to its specific region, and in
advanced disease stages - to distant foci.
The CO2 laser surgery has become a widely used clinical treatment in
otorhinolaryngology. Its major advantages include precise tissue removal with good
haemostatic effects and generally very good functional results [58]. In the surgery for
laryngeal cancer the trend in the last decades is clearly from the classical open partial
laryngeal resections and laryngectomy towards organ-preservation by endoscopic
5CO2 laser surgery or irradiation with curative intent [28,122]. The rich clinical
experience from the last few decades has proven the advantages of the CO2 laser
surgery for early stage glottic [16,41,93], supraglottic [15,28], oral and oropharyngeal
[58,118] and hypopharyngeal [24,96,105] squamous cell carcinoma.
However in advanced disease it is often difficult and even impossible to expose well the
whole tumor through the surgical laryngoscope. In such cases the tumor is usually
divided with the CO2 laser in several parts, which are excised separately [15,106]. This
approach was found useful for estimating the depth of tumoral infiltration under the
magnification of the operating microscope [2,95]. It is quite controversial whether this
piecemeal resection is oncologically acceptable as it seems opposed to the basic
principles of oncologic surgery [4,126]. The proponents of the piecemeal resections
refer back to two major types of studies. 1. Studies on the interaction between the tumor
and tissue (usually healthy one), showing some ability of the laser to seal the lymphatic
vessels on the cutting edge [29,36,120]. 2. Nonrandomized clinical studies, showing
similar results with endoscopic CO2 laser piecemeal resection and classical open
surgery and no evidence of increased incidence of metastases after the piecemeal
resection [15,41,104,105]. However in this inductive logic chain (from some specific
observation to a broader generalization) there is a gap, which has not been addressed by
any study in the reviewed literature, namely there are no studies, investigating the actual
influence of the transtumoral laser cut (piecemeal resection) on the incidence of
lymphatic metastases.
62. Study objective
On this background the aim of the present study was to compare the piecemeal laser
surgical complete (R0) tumoral resection with cold steel complete (R0) en bloc tumoral
resection in an animal model. For the study the VX2 SCC model in New Zealand White
rabbits was chosen. This is an established SCC model, characterised by early
predominantly lymphatic metastasing along a constant cascade similar to the one of the
human HNSCC. Both surgical approaches had to be compared in uniform conditions on
the following major aspects:
- Effectiveness for achieving local control and incidence of local recurrences
- Incidence of regional and distant lymphatic metastases
- Incidence of distant visceral metastases
73. Material and method
3.1. Study protocol
The animal use protocol was approved by the Institutional Animal Care Use Committee
(IACUC) of the government of Giessen, Germany, protocol number
VI 25.3-19 c 20-15 (1) MR 20/3-Nr. 25/2002. The experiments were performed in
accordance with the guidelines of the Declaration of Helsinki and in accordance with
the Public Health Service Policy of Humane Care and Use of Laboratory Animals [73].
Adult male specific pathogen free Iffa Credo New Zealand White (ICO:NZW) rabbits
weighing 3.0±0.6 kg (range 1.9-4.5 kg) were used. The animals were purchased from
Behring (Behring Werke, Marburg, Germany). The study protocol is schematically
presented on Fig. 1. After randomisation to the both study arms in 143 male New
Zealand White rabbits a VX2 squamous cell carcinoma was induced in a uniform way
on day 0. Male animals were preferred, because they have relatively less fatty tissue,
which diminishes anaesthesia risks and simplifies the neck dissection [42]. On day 8 a
complete (R0) resection of the tumour with curative intent was performed: for the first
group - with cold steel resection (CSR) en bloc; for the second group the cancer was
transected by the CO2 laser following which it was removed in two pieces - piecemeal
laser-surgical resection (LSR). On day 51 all animals were sacrificed and subjected to
evaluation of the tumoral spread. During the whole study period measurements of the
tumoral growth and body mass and temperature were performed on a regular base.
Figure 1. Study protocol: Randomisation (Rnd) and tumor induction (TuI) on day 0,
resection (Res) on day 8 and animal sacrifice on day 51. With asterisk the days when
the general condition and the signs of the tumoral disease were evaluated.
83.2. Induction of the VX2-carcinoma
3.2.1. VX2 cell suspension preparation
The original VX2 cell line was obtained from Prof. Dr. Robert J.J. van Es (Department
of Oral and Maxillofacial Surgery, University Medical Center Utrecht, Utrecht,
Niederlande) [111]. The cell line was propagated in-vivo by intramuscular passage in
the gluteal musculature of NSW rabbits (Fig. 2a, page 63). Two weeks after
implantation the animals were sacrificed. The dissected tumoral mass was processed
without delay. During the whole preparation the tumoral mass was cooled in DMEM
(Dulbecco's Modified Eagle's Medium, Biochrom AG, Berlin, Deutschland) on dry ice
at a temperature of 0-4 Co. The tumor was cut into several small pieces. Apparently
necrotic parts were removed. The viable tumor tissue was further minced with razor
blades and stirred through a 300 mm nylon sieve. The mass was again rinsed with cold
DMEM. After centrifugation at 3000 r.p.m. for 5 minutes the upper phase was pipetted
and removed. The lower phase containing the tumor cell suspension was aliquoted. The
number of cells in suspension was counted using a haemocytometer (Improved
Neubauer Ruling). Viability of cells was estimated by Trypan blue exclusion after
dilution 1:1 (Fig. 2b, page 63). The suspension was standardized at a mean density of
8-10x106 cells/ml and filled into 1 cc syringes.
3.2.2. Transplantation
The tumor was transplanted between the central auricular neuro-vascular bundle and the
caudal margin on the dorsal side of the auricle (Fig. 2c, page 63). The height of
transplantation was chosen at the approximate border between the middle and the distal
thirds. The targeted area of the auricle was wetted with warm water. In this way the fur
did not impair the visualisation. After introduction of the 0.5 mm needle in a
subcutaneous manner a small quantity of air was injected in order to dissect and elevate
9the skin from the underlying cartilage and so produce a subcutaneous pocket. In this
compartment 0.3 ml of the tumor-cell suspension was injected. Minimal regurgitation of
the suspension through the injection point could be observed in some animals, which
but did not lead to significant reduction of the injected volume.
3.3. Observation, measurements and documentation
At the beginning of the current study the general condition of the animals was judged by
an experienced animal tender. Care was taken to start the experiment only on animals in
a good condition, after the initial adaptation to the new milieu. During this period the
animals were visited daily and several parameters were noted as recommended by the
literature [42]. The body weight was measured with a commercially available scale
Multina Plus (Soehnle-Waagen GmbH & Co. KG, Murrhardt, Germany), with „weight-
lock“ function that compensates for the movements of the animal and allows precise
measurement. The measurements were recorded with an accuracy of 0.01 kg. The rectal
temperature was measured with a digital thermometer (TMP Tüshaus Medical Produkte
GmbH, Velen-Ramsdorf, Germany) over 4 minutes with an accuracy of 0.1 Co. The
measurement of the tumoral mass was done with a calliper with an accuracy of 0.05 mm
(Fig. 3a, page 64). The longest diameter and one perpendicular to it were measured. The
complete thickness of the tumor and the underlying auricle was measured too. The
tumor growth was recorded daily.
The macroscopic aspect of the tumor was described with a grading system, based on the
presence on tumoral bleeding, necrosis and crust (Fig. 3bc, page 64). For all these
characteristics a 4 level grading system was used (Table 1). For the bleeding:
0 - absence of any signs of bleeding; 1 - minimal traces of coagulated blood on the skin;
2 - capillary bleeding, fresh blood cloths on the skin; 3 - important bleeding from a
larger vessel, important blood traces in the cage from the night. For the necrosis: 0 - no
signs of tumoral necrosis; 1 - the tumor is soft, with signs of fluctuation upon palpation,
but the covering skin is intact; 2 - skin defect with necrotic tissues visible inside or
coming out through the defect; 3 - important tumoral necrosis with large skin defect.
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For the crust: 0 - no crusts; 1 - thin crust gluing the fur; 2 - well-developed crust,
covering small area of the tumor; 3 - thick crust, covering important surface of the
tumor. The neck status was clinically estimated by palpation on a daily basis. The
findings were recorded in the following way: 0 - no palpable or suspicious neck masses;
1 - suspicious structure, which could not well be differentiated from the normal
surrounding structures; 2 - clearly palpable mass. For larger masses approximate
dimensions in centimetres were recorded. Notes were taken for the general condition of
each animal, or other particular details not included in the above-described grading
system. The quantities of water and food eaten and feces and urines were daily closely
followed.
Grade Tumoral bleeding Tumoral necrosis Tumoral crust Neck LN
0 no bleeding no signs of
necrosis
no crusts no palpable LN
1 minor blood traces tumor fluctuation
under intact skin
thin crust gluing
the fur
suspicious neck
masses
2 capillary bleeding,
fresh blood cloths
small skin defect crust on a small
surface
clearly palpable
LN
3 important bleeding large necrosis thick, large crust size in cm
Table 1. Grading system for semiquantitative assessment of the tumoral and neck status
On the day of the surgical resection the weight and body temperature were measured
preoperatively and the size and morphology of the tumor and neck status were
examined and recorded with the animal already in anaesthesia.
After the resection the weight, body temperature and the presence of enlarged neck LN
were evaluated on a daily basis for 5 days in order to detect postoperative complications
from the anaesthesia or the intervention. Afterwards this control was done once a week
with last measurements on the day of sacrifice. If recurrences appeared at the resection
line their size (largest and perpendicular diameter and thickness) was measured weekly.
All the measurements of the tumoral size (with callipers) and the estimation of the size
of the LN metastases by palpation were done by one and the same investigator.
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3.4. Resection of the tumors
The resection was carried out on the 8-th day after the inoculation of the tumor.
3.4.1. Anaesthesia
The resection of the tumor was performed with the animals anaesthized with 5mg/kg
xylazinhydrochlorid (Rompun 2%, Bayer Vital GmbH, Leverkusen, Germany) and
100mg/kg ketaminhydrochlorid (Ketavet, Pharmacia GmbH, Erlangen, Germany) [42].
The dosis of the medicaments was calculated according to the body weight, measured
on the preoperative day. The anaesthetised animals were transported from the cages to
the operating theatre in carrying boxes. The depth of the anaesthesia was tested by the
standard approach of pressing tightly between the fingers of the lower pad. If the
animals reacted to this painful stimulus, complementary medication was given. Only
after evidence of deep anaesthesia the intervention was started. In the rare cases, when
the animals reacted to pain during the intervention it was stopped, complementary
medication was given and the work was continued after 5-10 min. After the intervention
the animals were transferred back to the cages and observed for 2 to 3 hours till
complete restoration of the voluntary mobility occurred.
3.4.2. Scalpel resection
The cold steel resection was performed as ablatio auris (Fig. 4, page 65). The resection
line was placed well proximal to the inferior tumor margin (1.5-2.5 cm). At the
beginning the fur at this level was shaved and the skin was cleaned with Softasept N
(B. Braun Melsungen, Melsungen, Germany). The medial auricle artery was ligated
proximal to the resection line. The auricle was cut with a scalpel no. 22. The bleeding
from the small skin vessels was controlled with monopolar coagulation. The skin along
the resection line was elevated on both sides to form 2-3 mm wide flaps, which were
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pulled and sutured together (4/0 Prolene®, curved PS-2 needle, Ethicon, Nordersted) in
order to cover well the cartilage. The wound closure was done predominantly with
continuous suture and only few single stitches if appropriate. The skin and the fur of the
animal were cleaned with water and consecutively with Softasept N. The sutures were
removed on the 7-th postoperative day. The same investigator performed all but two
resections. The resected specimens were marked with colour threads/pins. After each
resection the instrument set was carefully washed and sterilized in a Statim 5000
Cassette Autoclave (SciCan, Toronto, Ontario M3B 3P9 Canada) to avoid bacterial or
tumor cell transfer.
3.4.3. Piecemeal laser-surgical resection
For the laser-surgical resection the operating theatre was labelled with the appropriate
warning sign on the door and the access of other people was limited. Inside the surgeon
and the assistant wore special protecting glasses. For the laser-surgical resection the
animals were anaesthetised in the way, described in chapter 3.4.1. The fur was shaved
around the tumour. The skin was cleaned with Softasept N (B. Braun Melsungen,
Melsungen, Germany). The medial auricle artery was ligated proximal to the resection
line. The operating field was covered with wet cotton compresses to protect the animals
from incidental laser injuries (Fig. 5, page 66). The CO2 laser (Lumenis Compact Series
C40 - Lumenis GmbH, Dieburg, Germany) was set to continuous wave mode with
power settings of 10 watts utilizing the handpiece delivery system with built-in smoke
evacuation. The resection was performed in two stages. The first incision line passed
through the middle of the tumor, while the second was placed through healthy
surrounding tissues some 5 mm away from the visible border of the tumour. The
resected specimens were marked with colour threads/pins. The wound was left
uncovered, and healing was by secondary intention (Fig. 10, page 70). Only in 5
animals suturing of the part of the wound was necessary (4/0 Prolene®, curved PS-2
needle, Ethicon, Nordersted, Germany) to achieve complete haemostasis. In these cases
the sutures were removed on the 7-th postoperative day. The same investigator
performed all but four resections.
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3.5. Macroscopic and microscopic pathologic evaluation
3.5.1. Animal sacrifice
The animals were sacrificed on the 42-th postoperative day using an intravenous
application of 1 ml T-61 (Intervet Deutschland GmbH, Unterschleißheim), after being
anaesthetised with 100mg/kg ketaminhydrochlorid (Ketavet, Pharmacia GmbH,
Erlangen, Germany).
3.5.2. Dissection
The dissection was performed in a standard way in all animals. All obtained specimens
were put into glass vials, marked carefully with animal number, type of specimen,
unique identifier of the specimen and date of sacrifice. The specimens were fixed in 4%
neutral-buffered formalin. Of the auricle a 1 cm wide tissue band was cut along the
whole resection line and marked with colour threads/pins so the anterior, posterior distal
and proximal margins and the lateral and medial surfaces could be clearly identified.
For evaluation of the extent of metastatic spread to the regional LNs the ipsilateral neck
side was dissected with the animal lying in lateral position. The region was accessed
after a hockey-stick skin incision, starting from nuchal and extending along the back
and turning right and anteriorly at the level of the scapula. The skin flap was dissected
along the superficial fascia and elevated in a rostral direction, so the whole lateral and
anterior parts of the neck could be visualised. The jugular vein presented a major
landmark as the LN-groups are situated along it (Fig. 6, page 67). The parotideal LNs
lie under the parotid fascia along one of its branches - the caudal auricular vein. The
caudal mandibular lymph nodes are located between the superficial and the deep layers
of the cervical fascia at the bifurcation of the jugular vein between the linguofacial vein
and the maxillary veins. The rostral mandibular lymph nodes are located at the
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bifurcation of the linguofacial vein close to the posterior pole of the mandibular gland.
The dissection was started with opening of the superficial layer of the cervical fascia.
First the caudal mandibular LN group was dissected, followed by the rostral one. Last
the parotideal LNs were dissected. This sequence was found very useful as bleeding
from occasionally opened venous vessels in the parotid region complicates the
dissection in the other two regions. On the contrary, bleeding from the perijugular
regions does not disturb the work around the parotideal LN group. This approach was
found superior to previously described ones [21]. In cases when the LN could not be
identified macroscopically, the whole complex of soft tissues around the typical
localisations was excised as a single block and placed in 4% neutral-buffered formalin
for further serial sectioning. Often after several days in this solution the changes in the
tissue consistence allowed macroscopic identification of the LN – the fatty tissue
remained white and softer, while the LN became darker and palpable.
In the next step the presence of distant metastases was evaluated with the animal in
supine position. The medial skin incision started below the mandible and extended to
the pelvis. After preparation of the skin flaps the ribs were cut 1-2 cm laterally to the
sternum with sharp scissors, starting from the superior thoracic aperture. After removal
of this sternocostal block the larynx was freed from the pharynx and excised. With a
gentle pull and sharp dissection the trachea was separated from the oesophagus in a
caudal direction. It served as a handle for the extirpation of the attached lungs and heart.
The lungs were separated, sliced in 3-4 mm thick slices, examined for macroscopic
changes and put into marked vials. The metastases were counted and the diameters of
the largest and smallest measured and recorded. The trachea was opened along the
posterior wall and examined for metastases. Followed section of the diaphragm and
preparation of the liver. It was sliced into 1 cm thick slices and examined for
macroscopic changes. The whole thoracic and abdominal cavities were examined for
metastases.
The described sectioning technique allowed clean preparation of the regions of interest
and macroscopic evaluation of the regional and distant spread of the tumoral disease.
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3.5.3. Histological preparation and evaluation
After fixation in formalin for at least 48 hours, the specimens were further processed
and embedded in paraffin for histological preparation. Of the majority of specimens
(main tumor, resection line at sacrifice, lungs and liver one hemalaun and eosin (H&E)
stained slide was made per block. Of the complete ND-specimens serial sections were
prepared. The slides were cut on a sliding microtome at 100 µm. The slides were
examined on conventional light microscope. All specimens were checked for signs of
tumoral invasion. For the ND-blocks the total number of studied and metastatically
involved LN was noted. In cases of uncertainty complementary slides were prepared
from the initially preserved specimen or the paraffin blocks.
3.6. Data processing and analysis
3.6.1. Data processing and analysis
For the initial planning of the experiment timetable MS-Excel was used. For each
animal a printed form was prepared and labelled with the appropriate number
(Appendix page 75). On this form all parameters from the observation and
measurements together with details on the surgical intervention, as well as the findings
of the sectioning were recorded in an uniform way. The data from these forms were
entered in a specially created databases under Epi Info 6.04d (Centers for Disease
Control and Prevention, Epidemiology Programm Office, Division of Public Health
Surveillance and informatics, Atlanta, U.S.A.). For the analysis the separate databases
were merged with the animal number used as a unique identifier. For the statistical
analysis along with Epi Info SPSS for Windows v. 11.5 (SPSS Inc., Chicago, Illinois)
was used. Categorical data (frequencies) were analysed using crosstabulation and chi-
squared test for independence. In cases of small samples Fisher‘s exact test was used.
For comparison of nominal-level variables between groups unpaired t-test was used. For
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statistical significance two-tailed test was used. Probability levels less than .05 were
considered statistically significant. Relationships were analysed with Pearson product
moment correlation coefficient [69].
3.6.2. Exclusion criteria
Four of the 143 animals were not included in further analysis. Three of them were lost
intra- or immediately postoperatively because of anaesthesia problems. In the last
animal the implanted tumor did gradually regress.
CSR LSR
Started animals 73 70
Spontaneous tumor regression 1 0
Intra- perioperative deaths 2 1
Animals included in the main analysis 70 69
Table 2. – Animals excluded from the study
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4. Results
From the total of 143 animals at the beginning of the experiment one was excluded
because of clinical regression of the tumor and 3 were lost on intra- an early
postoperative complications related to the anaesthesia. One hundred thirty-nine animals
were included in the final analysis. The mean follow up was 5.85±0.61 weeks (range
2-6). Eleven animals died before the planned timepoint (51-st day). In nine of them the
death was related to the main disease – tumor progression on day 36.8±8.2 (23-50) after
the tumor induction. The rest two died of pneumonia on days 38 and 42. Of the tumor
related deaths 3/9 were in animals with local recurrence, in 9/9 with LN involvement
and in 8/9 with distant metastases. There was a high negative correlation between the
number of lung metastases and the survival (r=-0.89 p<0.05). The survival did not
correlate with the maximal size of the LN metastases.
4.1. Tumor growth
4.1.1. Success of transplantation
The tumor take rate was 99.3% - a figure that significantly differs from the results of
other research groups – 78%-83% [23,111]. Only one animal was excluded from the
study because of unsuccessful tumor transplantation. In this animal the tumor had an
atypical aspect and its size gradually diminished starting from the 4-th day. Under the
skin, which regained its normal colour there was still a small hard palpable mass, which
resembled scar fibrosis. The histological examination showed resorbtive changes and
fibrosis at the site of initial inoculation. Histologically in the centre of the mass 2
regions with vital tumoral cells were found. Despite the presence of potentially
proliferating tumor the animal was not included in the further analysis because of the
small and atypical primary tumor, which was incomparable to the tumors in the other
study animals. In 33/139 animals (23.7%) tumor size reduction in 2 diameters was
observed between the second and the third days. The shrinkage in the longitudinal
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diameter was 0.73±0.58 (range 0.05-2.5 mm) and in the transversal one 0.52±0.67 mm
(range 0.05-3.20 mm). This is to be explained with the drainage of some of the VX2
tumor cell suspension through the injection channel, with partial resorbtion of its liquid
fraction and decrease in the traumatic oedema caused by the manipulation. Nevertheless
at the moment of tumoral resection in all animals the tumor had viable aspect with all
dimensions increased, i.e. apart of the one excluded animal in no other signs of
spontaneous tumoral regression were observed.
4.1.2. Tumor growth
For comparison of the tumor growth in both study groups two types of variables were
used - absolute dimensions of the tumor and increase of the tumor mass.
The initial tumor dimension were slightly bigger in the LSR group compared to the
CSR group for the longitudinal diameter with 8.3% (mean 0.8 mm), for the
perpendicular diameter with 18.9% (mean 1.4 mm) and for the thickness with 24.2%
(mean 0.8 mm). These differences appeared statistically significant.
CSR LSR
Tumor length [mm] 9.6±1.9 10.4±1.9
Tumor width [mm] 7.4±1.8 8.8±1.5
Tumor thickness [mm] 3.3±0.6 4.1±0.9
Table 3. Initial dimensions of the tumor for both the therapeutic groups.
At the time of resection the maximal dimensions of the tumors in the LSR group
showed to be bigger than those of the CSR for the longitudinal diameter with 12.7%
(mean 2.3 mm), for the perpendicular diameter with 8.3% (mean 1.1 mm) and for the
thickness with 17.2% (mean 1.2 mm). These differences appeared statistically
significant.
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CSR LSR
Tumor length [mm] 18.1±4.3 20.4±4.3
Tumor width [mm] 13.2±3.1 14.3±2.4
Tumor thickness [mm] 7.0±2.5 8.3±2.1
Table 4. Maximal dimensions of the tumor for the both therapeutic groups.
The reported differences should be attributed mainly to the technique of tumor
induction. Though in all animals 0.3 cc standardized on the cell count suspension was
injected there are other important mechanical factors that influence the procedure. A
relatively long subcutaneous needle tunnel is indispensable for the successful injection,
because it provides tight sealing around the needle for the pneumatic dissection. After
the needle withdrawal this tunnel allows some regurgitation of cell suspension and so
gets contaminated, which results in complementary tumor growth. The cell suspension
itself though standardized for the cell count could differ in its viscosity and so
influences the dissection in the subcutaneous plane and the regurgitation. The above
differences could be induced or influenced by these mechanical factors.
The tumor growth, which is a better measure of the tumoral viability and
aggressiveness, than the absolute dimensions, was estimated by the percentage increase
of the tumoral dimensions.
CSR LSR
Tumor length increase [%] 192.3±53.8 199.1±46.0
Tumor width increase [%] 184.7±56.4 164.8±29.7
Tumor thickness increase [%] 217.8±80.7 204.8±46.4
Table 5. Percentage increase of the dimensions of the tumor for the both therapeutic
groups.
The percentage increase of the tumor dimensions was compared for the both study
groups and the results showed to be homogenous. The increase in the longitudinal
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diameter was bigger in the LSR group than in the CSR with 3.5% without being
statistically significant. On the contrary the increase of the perpendicular diameter and
the thickness were bigger in the CSR group with 12.1% (p<0.05) and 6.3% (n.s.)
respectively.
Tumor length CSR group
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Figure 7a. .Tumor growth over the 8 days after tumor implantation, measured by the
longitudinal diameter of the tumor in mm for both therapy groups (mean ±SD)
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Figure 7b. Tumor growth over the 8 days after tumor implantation, measured by the
transversal diameter of the tumor in mm for both therapy groups (mean ±SD)
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Figure 7c. Tumor growth over the 8 days after tumor implantation, measured by the
tumor thickness in mm for both therapy groups (mean ±SD)
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Figure 7d. Tumor growth over the 8 days after tumor implantation, measured by the
tumor base surface in cm2 for both therapy groups (mean ±SD)
With tumor progression partial necrosis and bleeding could be observed. Tumoral
necrosis was observed in 59 animals (24 from the CSR and 33 from the LSR groups).
Fifty animals had tumor necrosis degree 1 (softening/fluctuation) and 7 had degree 2
(minimal skin defect) as defined in Table 1 on page 10. The necrosis was detected on
the 8±1 day (7.8±1.2 for the CSR and 8.2±0.8 for the LSR groups).
24
Only tumoral bleeding after the 4-th day was regarded as tumor related. Sings of
bleeding before this timepoint were attributed to the trauma during inoculation of the
cell suspension. Tumoral bleeding was observed in 9 animals (6 from the LSR and 2
from the CSR groups). In all of these cases this was minimal bleeding grade 1
(Table 1, page 10). The bleeding appeared on day 7.4±0.7 (6.7±0.6 for the CSR and
7.8±0.4 for the LSR groups). The earlier appearance of the bleeding in the CSR group
was the only parameter that significantly differed between the both groups. Nevertheless
the number of animals included in this analysis is too small - only 8.
Of the animals that later developed recurrences at the resection site 3/9 (33.3%) had
initially necrosis of the primary tumor grade 1 and 1/9 (11.1%) tumoral bleeding
grade 1. Of the animal with local control 54/130 (41.5%) had tumoral necrosis – 47
cases with grade 1 and 7 cases with grade 2. Eight animals of this subgroup of 130 with
local control (6.2%) had grade 1 tumor related bleeding.
The tumor recurrences presented with a different macroscopic aspect. While the main
tumor could be approximated to a split half spheroid the recurrences were thicker and
more rounded – approximation to a whole spheroid. This could be attributed to the way
of initiation and the different location. The initial tumors were injected in an artificial
pouch with a slit-like form between the mechanically quite resistant cartilage and tense
skin, where as the recurrences developed from one centre like a sphere in the proximal
part of the auricle, where the soft subcutaneous tissue is much thicker and offers more
space for tumor growth.
4.1.3. Histological findings
4.1.3.1. Tumor morphology
The VX2 SCC presents as a solid tumor with characteristic intratumoral patterns and
interaction with the surrounding tissue (Fig. 8, page 68). Usually with growth of the
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tumoral mass a clear delineation between an active periphery and the centre becomes
evident. The centre often shows necrotic changes. Vital tumor cells are usually
concentrated around the blood vessels. Intratumoral blood vessels are few if any. In
tumors without necrotic changes rarely vessels without erythrocytes and with extremely
thin walls comprising only one layer of endothelial cells could be observed - most
probably lymphatics. On the contrary the periphery is active and proliferates in the
surrounding tissues. Here the active vital tumoral tissue could be surrounded by
lymphohistiocytic infiltrate. The perichondrium and the cartilage seem to present a
relatively resistant barrier for the tumor growth as their infiltration could occur usually
at later stages [111]. On the other hand the tumor infiltrates readily in the overlying
epithelium. In the subcutaneous tissue the tumor gives small emboli consisting of
multiple well-adhered together cells. These emboli could be found in the lymphatic as
well as in the blood vessels (Fig. 8, page 68).
The VX2 carcinoma used in our rabbit model is a typical squamous cell carcinoma with
a very low differentiation and anaplastic appearance. The cells are highly pleomorphic.
They are polygonal, contain large cytoplasm and enlarged nuclei. The cell borders are
usually well delineated and sharp, the nucleus is centrally located. Nuclear enlargement
and pleomorphism is pronounced. The nuclear chromatin is markedly hyperchromatic,
with a coarsely granular pattern and marked chromatin clumping. Mitotic figures are
commonly observed. The prominent nucleoli and the mitotic figures if evident, prove
the low differentiation of the tumor.
4.1.3.2. Resection related aspects
Both resection tools used (scalpel and CO2 laser) produced clearly distinguishable tissue
changes. The scalpel resection results in a sharp cut through all tissue layers of the
auricle (Fig. 9, page 69). At the moment of sacrifice complete wound healing was
observed with fibrosis and covered by epithelium.
The CO2 laser resection with 10 watts power setting in continuous wave mode results in
narrow necrotic zone with minor burn changes. Occasional carbonisation particles could
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be found. On the resection surface the soft tissues were covered with a thin coagulation
layer that was amorphous. No distinct structures (tissues, cells or matrix) could be
identified in this layer. All structures were welded in a homogenous mass. This layer
was not present on the cartilage border. Here coagulation was visible only in the
perichondrium. In the tumoral tissue similar changes were observed. In some necrotic
areas the coagulation layer looked thinner or was partially absent.
At the moment of sacrifice complete wound healing was observed with fibrosis that was
covered by epithelium. The fibrous scar was most marked on the curve between the
transversal and longitudinal parts of the resection line. Its contraction in the process of
maturing of the fibrosis led in some cases to minor deformation of the rest auricle
(Fig. 10b, page 70).
4.2. Lymph node metastases
4.2.1. Incidence of lymph node metastases
Of the 139 animals, which entered the second part of the protocol, in 56 (40.3%) LN
metastases were present (Fig. 6, page 67). In 56/56 there was metastatic involvement of
the first echelon parotid LN (level I). Five animals had two clearly delimited tumoral
masses in the parotideal region, each with thick capsule. In 10/56 animals (17.9%)
further LNs were involved too. In 9/56 (16.1%) LNs from the caudal mandibular group
(level II) and in 1/56 (1.8%) LN from the rostral mandibular group (level III) were
involved. Five animals had involvement of more than one LN in level II: in four
animals there were 2 and in one animal 3 LN metastases in level II.
All animals with metastases in levels II and III had also metastases in level I. No skip
metastases from the tumor to levels II and III were observed. This comes to underline
the importance of the first echelon parotideal LN. In 100% of the cases the initial
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lymphogenic metastatic spread involves it (Fig. 11).
Figure 11. Pathways for the lymphogenic metastatic spread. The width of the arrows is
proportional to the relative incidence.
All animals with recurrences at the primary site had LN metastases. Of them in 9/9
(100%) metastatic involvement of the first echelon parotid LN (level I) and in 3/9
(33.3%) of a second LN from the caudal mandibular group (level II) was present. No
metastatic involvement of the LNs from the rostral mandibular group (level III) was
observed in any of the animals with local tumoral recurrence.
Of the 130 animals, which were proven to be tumor free at the primary site after the
resection (complete local control), in 47 (36.2%) LN metastases were present (Fig. 12).
In 47/47 there was metastatic involvement of the first echelon parotid LN (level I). In
7/47 (14.9%) further LNs were involved too. In 6/47 (12.8%) LNs from the caudal
mandibular group (level II) and in 1/47 (2.1%) LNs from the rostral mandibular group
(level III) were involved. Of the 9 animals with local recurrence of the tumor in 9
(100%) LN metastases were present. In 9/9 there was metastatic involvement of the first
echelon parotid LN (level I). In 3/9 (33.3%) further LNs were involved to - from the
caudal mandibular group (level II).
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Figure 12. Incidence of LN metastases at levels I, II and III for the animals with local
recurrence of the tumor and those with complete local control achieved after the
resection, presented as percentage of the total number of the animals in each group.
Compared on the incidence of LN metastases the two therapeutic groups showed
significant differences (Fig. 13). Of the animals with en bloc cold steel ablatio in 16/65
(24.6%) metastases to regional LNs were found. In all cases involvement of the first
echelon parotideal LN was observed (level I). Two of 65 animals had involvement of
LNs from further levels – one of level II (the caudal mandibular group) and one of level
III (the rostral mandibular group). Of the animals with piecemeal laser-surgical
resection in 31/65 (47.76%) metastases to regional LNs were found. Again in all cases
involvement of the first echelon parotideal LN was observed (level I). Five of 65
animals had involvement of LNs from further levels all of level II. The Pearson’s
Chi-Square test of independence showed that the piecemeal LSR tended to lead to more
LN metastases in the echelon parotideal LN (31/65 or 47.7%) as compared to the en
bloc cold-steel ablatio (16/65 or 24.6%) p=0.01. This difference appears statistically
significant. Similar tendency was observed for the metastases to other neck levels 7.8%
for the LSR vs. 3.1% for the CSR group without being statistically significant.
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Figure 13. Incidence of LN metastases at levels I, II and III for the cold steel resection
group and laser-surgical resection group, presented as percentage of the total number
of the animals in each group. Only animals with complete local tumoral control are
included.
4.2.2. Pathological evaluation
The parotideal LN metastases had mean maximal diameter of 36.3±16 mm and minimal
25.6±11.7 mm. The LN metastases to other neck levels had a mean maximal diameter
of 10.4±3.2 mm, and minimal one 5.7±2.1 mm. The largest dimension of a LN
metastasis was 78 mm, the smallest – 3 mm. The metastases presented with a thick
fibrous capsule. They were usually firmly connected to the underlying neck structures.
In five animals in the parotideal region two tumoral masses were found, each with thick
capsule. Though wrapped closely together by the fascia and tumor induced fibrosis they
were clearly delimited by own fibrous capsules without signs of tumoral infiltration
between them. The LN metastases in the parotideal region lied in a close intimacy with
the large collector vein of the auricle - the caudal auricular vein and had an important
common contact surface. Nevertheless there were no macroscopic signs of bleeding
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from vessel erosion. When sectioned the metastases were filled with caseous material
sometimes with partial colliquation.
A total number of 1985 serial histologic cuts revealed 674 LN (Table 1). The mean
yield of LN per animal (one neck side) was 4.13±1.37. In all levels I (parotideal region)
152 LN were studied (mean 1.09±0.37, range 0-2). In 15/139 (10.8%) animals in this
region 2 LN were found. In all levels II (caudal mandibular region) 209 LN were
studied (mean 1.5±0.74, range 0-3). In all levels III (rostral mandibular region) 213 LN
were studied (mean 1.53±0.78, range 0-3). The respective incidence of metastases was
59/152 LN in level I plus 5 cases of double LN metastases or a complementary
metastasis in the parotis, 15/209 LN in level II and 1/213 LN in level III.
Parotideal
region
Caudal
mandibular LNs
Rostral
mandibular LNs
Total
Number of LN
examined
152 209 213 574
Mean yield pro animal 1.09±0.37 1.5±0.74 1.53±0.78 4.13±1.37
Total number of
metastatic LN
61 15 1 77
Metastatic LNs as %
from all LNs examined
42.1% 7.2% 0.47% 13.4%
Table 6. Distribution of the LN findings to the three regions of interest (parotideal,
rostral and caudal mandibular) for the whole cohort.
4.2.3. Histologic findings
The first gross impression of the metastatic LN is the absence of the typical LN
structures. The normal LN has a central hilar part with blood vessels followed by a
medullar zone with sinuses and medullar cords all filled with lymphocytes
(Fig. 14a, page 71). In the periphery is the cortex of the lymph node. Between the
medullar and the cortical zones lies amorphic paracortex. The cortical zone contains the
lymphatic nodules. They are characterised by a relatively eosinophilic germinal centre
and basophilic mantle zone (towards the hilus) and a cap (towards the periphery). Under
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the fine capsule that surrounds the whole LN a narrow subcapsular sinus could be
observed.
The histologic picture of the LN metastases is characterised by the absence of all above-
mentioned structures. Instead the metastases show several concentric zones
(Fig 14b, page 71). The central one is usually necrotic. It is characterised by the
presence of abundant granular eosinophilic debris. This is a sign, that the tumor has
outgrown its blood supply. Larger metastases often have central cavitation. The zone of
active tumoral growth is towards the periphery (or seldom around intratumoral blood
vessels). Here strands and nests of vital tumoral cells are observed. The third concentric
zone is the LN capsule. A common phenomenon is its thickening. This is due to the
diffusion of toxic substances from the metastasis to the surrounding tissues. These
substances elicit desmoplastic reaction, characterised by excessive growth of dense
fibrous tissue.
Some of the enlarged LN, detected by palpation or at dissection were found tumor free.
The histological changes observed were mainly due to reactive processes. In sinus
histiocytosis the sinuses are dilated, palely staining and are separated by thin projections
of darker staining lymphoid tissue. The activated histiocytes are characterised by their
irregular cell form with projecting cytoplasmatic processes and a nucleus with overall
vesicular appearance, due to the peripheral clumping of the dispersed chromatin. The
cytoplasm may show intense eosinophilia. In cases when in the draining area of a LN lie
necrotic tissues rich with lipoid materials, foamy macrophages may be observed
(Fig 14d, page 71).
Another type of LN enlargement observed presented the toxic inflammatory changes.
The toxic substances produced by the tumor and the tissue necrosis induce local
inflammatory process that involves the LNs in the draining area. In such activated LNs
the normal structure may be substituted by a diffuse cellular process or by fibrosis. The
cellular infiltration is patchy. The medullar and cortical zones and the follicles are
replaced by sheets and clusters of large pale cells. Some islands of surviving lymphoid
tissue may still be present. Small foci of histiocytic giant cells or necrosis could be
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observed too. Important argument for the absence of direct tumoral invasion of the LN
is the absence of cellular atypia in such infiltrates (Fig 14c, page 71).
4.3. Incidence of recurrences
Of the 139 animals that survived the anaesthesia and the surgical intervention in 9
(6.5%) local tumoral recurrences developed. In eight cases this was 1 tumoral mass and
in one – multiple masses. The tumor recurred at the resection line in 5 (7.1%) animals
of the CSR group and in 4 (5.8%) from the piecemeal LSR group (Fig. 16). The
intergroup difference is not statistically significant. At the point of sacrifice the tumoral
masses had mean longitudinal diameter of 30.2±17.5 mm and transversal one
19.3±10.3 mm. The recurrent tumor if presented as surface area [111] was 6.5±5.6 cm2
large. The recurrences became clinically evident during the second postoperative week
in 5/9 (55.6 %), the third in 3/9 (33.3%) and the fourth week in 1/9 (11.1%) animals.
Such a late appearance of recurrences shows, that the VX2 tumoral cells could survive
for an important time in the host, before they start to proliferate.
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Figure 16. Incidence of local tumor recurrences for the cold steel resection group and
laser-surgical resection group, presented as percentage of the total number of the
animals in each group.
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4.4. Distant metastases
4.4.1. Incidence of distant metastases
At section the abdominal and thoracic cavities and organs were examined for the
presence of macroscopic metastases. In no case distant metastases were observed at
other locations than lungs. In one animal tumoral mass was found on the parietal pleura,
but it was obvious contact involvement by a pulmonary one. That is why in this chapter
only lung metastases are reported.
Of the 139 animals, which entered the second part of the protocol in 19 (13.6%) lung
metastases were present. In 3/19 the metastases were unilateral and in 16/19 – bilateral.
Of the cases with unilateral lung metastases in two the ipsilateral to the tumor and in
one the contralateral lung were involved. Animals with tumoral recurrence had
significantly higher incidence of lung metastases (6/9, 66.7%) than those with local
control (13/130, 10%), p<0.001 (Fig. 17).
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Figure 17. Incidence of distant metastases for animals with and without local tumoral
recurrence, presented as percentage of the total number of the animals in each group.
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All animals with lung metastases had also neck LN metastases. In 19/19 there was
involvement of the first echelon parotideal LN and in 5/19 complementary LN from the
caudal mandibular group were involved. Pathologically the metastases were
predominantly multiple.
Animals that had no local tumor recurrence and only regional LN metastases had
significantly higher incidence of lung metastases (13/47, 27.7%) than animals without
regional tumor disease (0/83, 0%) p<0.001 (Fig. 18). No cases with skip metastases
were observed.
0
10
20
30
40
50
60
70
80
90
100
regional LN involvement
(n=47)
no regional LN
metastases (n=83)
100%
Distant metastases
Figure 18. Incidence of distant (pulmonary) metastases for animals with neck
metastases, which are tumorfree at the primary localisation, presented as percentage of
the total number of the animals in each group.
Of the 130 animals with complete local control thirteen (10%) had lung metastases. The
incidence for both treatment groups (CSR and piecemeal LSR) was similar - 8/65
(12.3%) for the CSR and 5/65 (7.7%) for the LSR (Fig. 19).
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Figure 19. Incidence of distant (pulmonary) metastases for animals with local control
for the cold steel resection group and laser-surgical resection group, presented as
percentage of the total number of the animals in each group.
4.4.2. Pathological evaluation
Apart of the general incidence, another interesting aspect of the metastaftic spread to the
lungs presents the morphology of the metastases – their count and size
(Fig. 20, page 73). The mean number of unique seedings pro animal varied in a very
large range from 1 to 172 (in both lungs) with a mean value of 52.2±60.8. The total
number of lung metastases didn’t differ significantly between the group with tumor
recurrence (34.83±67.5) and for the group with local control (60.8±58.4). The animals
that underwent cold steel resection had significantly less metastatic nests (15.1±18.9)
versus 110.4±58.4 for those subjected to transtumoral laser-surgical resection
(p<0.001). In the animals with local control at the primary site, those from the CSR
group had again significantly smaller number of unique seedings in the lungs
(18.7±23.1) compared to the LSR group (119.8±33.4 p<0.01).
The macroscopic aspect of the lung metastases was quantitatively evaluated by the
diameters of the largest and smallest ones for every animal. The largest lung metastasis
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had maximal diameter of 35 mm, and the smallest one – 4 mm. The minimal and
maximal diameters of the lung metastases in animals with local control were
comparable for the both therapy groups.
CSR LSR
Maximal diameter of unique
lung metastasis [mm] 21.00±10.1 16.6±9.2
Minimal diameter of unique
lung metastasis [mm]
9.3±4.8 5.4±3.9
Table 7. Maximal and minimal diameters of the lung metastases in the both therapeutic
groups. Only animals with local control are included. The minimal and maximal
diameters are measured from different metastases.
Three patterns of metastatic involvement of the lungs were identified (Fig. 21). Type A
is characterised by the presence of single or few large metastases with few small ones
and large areas of uninvolved lung tissue. In type B the lungs were filled with multiple
small metastases, so sometimes normal parenchyma could hardly be found. Type C
(mixed pattern) is characterised by the domination of single or few large metastases
over fewer metastases of comparatively small size evenly distributed all over the lungs.
Figure 21. Macroscopic patterns of metastatic involvement of the lungs.
The macroscopic sectioning of the specimens showed, that the metastases were
relatively hard, elastic, well differentiated from the surrounding parenchyma. No
tendency of the metastases to coadunate was observed. This supposes that the large
metastases have probably disseminated at an earlier time point compared to the small
ones, and grew more over longer time, rather than they present simply multiple
coadunated small ones.
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Though statistically not significant the following trend could be observed (Table 8). The
distant metastases of the animals with cold-steel ablatio auris tended to be of type A and
C with few large dominating metastatic focuses and several smaller ones. The distant
metastases of the animals with transtumoral laser surgical resection tended to be of type
B with multiple, quite synchronous small metastases.
A B C Total
CSR 3 0 5 8
LSR 0 4 1 5
Total 3 4 6 13
Table 8. Incidence of the three types of macroscopic lung involvement for animals
without local recurrence from both therapy groups
4.4.3. Histologic findings
The lung metastases presented as well delineated tumor masses (Fig. 22, page 74). They
were surrounded by a pseudocapsule resulting from the compressed parenchyma and
not like in the LN metastases by a fibrous capsule. Nevertheless here again the typical
pattern of concentric layers was observed with vital cells predominantly in the periphery
and central necrosis. Blood vessels and cartilage containing bronchi seem to be quite
resistant to the tumor invasion. In their spatial progression the metastases reached to
these mechanical „obstacles“ and bypassed them from the side, rather than to infiltrate
and destruct them. Sometimes large vessels or bronchi were found within the tumoral
necrosis. In multiple metastases there were well marked septa of pseudocapsule between
the individual metastatic seedings. The tumors did not show tendency to coadunate.
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5. Discussion
5.1. The auricular VX2 carcinoma as an animal model for HNSCC
The VX2 SCC is an established animal model of neoplastic disease. Initially Shope and
Hurst observed spontaneous malignant transformation of a papilloma viral infection in
rabbits [101]. Kidd and Rous succeeded to obtain a cell line from this carcinoma, which
could be transplanted further to other animals and became gradually virus independent
[48]. The difficulties with the low take rate of the tumor, its propagation and slow
growth the first investigators had, are nowadays well under control. The actual VX2
SCC cell lines are characterised by aggressivity and predictable induction rates [112].
Reliable reproducible methods have been established for their preservation and
propagation [100,111]. The microvascular architecture of the tumor is well studied
[62,88,116,124]. Since the 1960s the VX2 tumor has been used in a large variety of
experimental studies. Intramuscularly induced tumor has been used for evaluation of
techniques for minimally invasive tumor ablation by vacuum-assisted excision [10],
MRI-guided focused ultrasound hyperthermia [82]. Herborn et al. reported on the
possibilities of the interstitial MS-325 enhanced lymphography for tumours induced in
the dorsal footpads. The technique allowed detailed visualization of the lymphatic
pathways of drainage and the lymph nodes along them (poplyteal, inguinal, iliac,
paraaortal). Though in a totally different localisation and system the tumor showed
tendency for predominantly lymphatic metastases [39]. VX2 carcinomas have been
successfully induced in parenchymal organs – lung, kidney and liver [32,97]. Here the
possibilities of radiofrequency ablation have been tested [68]. VX2 implantation has
been described as a model for gastrointestinal tumor [71] and a model of peritoneal
dissemination of a gastrointestinal tumor [70]. The possibilities of chemotherapy for
cancer with different primary localisations have also been evaluated in VX2 model
[20,32,71,97].
Of particular interest are the experiments based on VX2 SCC auricle model. In this
experimental setting the relation between the primary tumor and its regional and distant
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metastases plays an important role. The primary tumor is easily accessible – completely
exposed to be observed and precisely documented. Different diagnostic and therapeutic
interventions can be readily carried out. As the ear is a periphery structure far from
important organs, vessels and nerves the tumor growth and manipulations on it cause
less discomfort for the animals. The ear model is characterised by topographically and
timely constant metastatic pathways. Tumor spread occurs initially along the lymphatic
vessels, affecting a well-studied cascade of LNs that again could be easily accessed. At
later stages the metastatic process involves distant sites – the lungs. This
chronologically and topographically reproducible biologic process is in its nature
analogue to the process of regional and distant metastatic spread of the SCC of the head
and neck in humans [23,111]. Here to every tumor location in the upper aerodigestive
tract correspond certain regional lymph nodes that are usual sites of metastases from
this primary locations [57,90,117]. Apart of this lymphatic spread tumoral cells may
further propagate from the primary site and the involved LN with the blood circulation
to distant locations (usually the lungs, liver or bones) [27,34]. From this background the
SCC of the head and neck is not just a tumor in this region, but a multilevel pathologic
process, determined by the spread from this primary locus to its specific region and in
advanced disease stages to distant foci. Another aspect: induced on the auricle the VX2
carcinoma becomes a tumor of the skin of the head and face. In humans malignancies
with such localisation give metastases to the LNs within the parotid gland [109]. In the
rabbit auricle model the first echelon metastases involves the parotideal LNs too. Some
histologic and even biologic similarities on macromolecular level between the VX2
SCC and human HNSCC have also been reported [64]. The VX2 auricle model has
been used for evaluation of chemotherapy protocols [20], optimisation of intraarterial
tumor embolisation [112-114], immunomodulation [98,110] and study of the
metabolism of the tumor [65].
5.2. General study results
By the piecemeal CO2 laser surgical resection in our animal model we observed
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phenomena and results similar to those known from the clinical practice in humans. The
laser allowed for extremely precise cutting with minimization of the surgical wound,
simplification of the procedure, reduction of the operative time [67]. Here the auricular
VX2 carcinoma model proved one of its major advantages – the easily accessible
primary tumor. This helped performing the resection in an uniform way without being
limited by the endoscopic approach [46,126]. The laser beam was operated in
continuous wave mode with power settings of 10 watts. With these working parameters
it provided good coagulation of the small vessels – another important advantage for the
clinical practice [115]. The cutting properties of the laser beam together with its
haemostatic effect allow for cutting with a precision never achieved by another
instrument. As a result the secure margins around the tumor could be reduced to only
few millimetres, comparable to those used in human endocopic resection. In our
experimental setting this approach led to preservation of the central vessel bundle and
more than the half of that portion of the auricle, which had to be resected in the scalpel
group in order to achieve secure margins of at least 1 cm, as aimed in the classical
oncologic surgery. This preserved tissue volume and the relative aesthetic benefit
corresponds in the endoscopic laser surgery of the upper aerodigestive tract to function
preservation. In anatomically complex organs like the larynx, tongue and
(hypo)pharynx every millimetre normal tissue saved is beneficial for the rest
respiratory, protective, alimentary and phonatory functions.
The similar incidence of local tumor recurrences between the piecemeal LSR and the
CSR groups comes to show that the minimization of the volume healthy tissue resected
is feasible and in no way at the cost of less oncologic radicality. The observed
recurrences in both groups after a R(0) in sano resection could hardly be attributed to
the surgical technique. They are probably an expression of particularities in the biologic
behaviour of the VX2 SCC. The histologic slides showed that the border between the
tumor and the healthy tissue is quite clear. The tumor did not show tendency to infiltrate
or give projections far away in the periphery (per continuitatem). It grows as a solid one
with active periphery giving multiple emboli of cancer cells into the peritumoral lymph
and blood vessels. Lymph stasis in certain areas during and after the resection could
lead to a stop in the movement of these emboli and help their local adhesion. In this way
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local metastatic colonization develops. After different periods of time some of them
could give rise to a recurrence. The interval of time between the resection and the
apparition of the recurrent tumoral mass was quite variable. The most early recurrences
were detected 14 days after the resection, the latest one - 28 days after the resection.
Without being sutured but just left open instead, the laser surgical wounds healed
without complications. No postoperative bleeding, wound dehiscence or infection were
observed in the LSR group even though some of the animals used to grate on the ear.
The healing process was slowed down and was per secundam intentionem – commonly
observed phenomenon after laser surgery [18,36,58]. This resulted in a more marked
fibrosis. At the point between the transversal and longitudinal parts of the resection line
a pronounced scar developed, which caused in several animals some deformation of the
auricle (Fig. 10, page 70).
5.3. Lymphatic metastases – possible influencing factors
The observed incidence of metastases after ablatio auris and longterm local control
(24.6%) confirms other reports in the literature with analogue experimental setting. In
their experiment Dünne et al. sacrificed the animals on the 7-th day after the induction
and detected micrometastases in the parotideal LN in 25% of the cases [21]. In our work
the primary tumor was resected at this timepoint so no further metastatic spread could
develop, but the animals were left alive for further 42 days. During this time the
metastases grew and even necrotised. Our setting is analogous to the clinical situation
with resected primary tumor (R0) and „wait and see“ approach to the neck. Nevertheless
both experiments show the background dissemination, which is dependent only on the
time after the tumor induction (i.e. tumor size). This means that at this timepoint in 1/4
of the animals the metastatic spread has involved the first echelon regional LN though it
is still not enlarged. It remains unclear whether all micrometastases to the LNs would
progress. The incidence of LN metastases in the VX2 auricle SCC model has been
shown to be independent from the primary tumor inoculation technique [111]. In this
way the VX2 auricle model corresponds to the natural history of the HNSCC in
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humans. Here the incidence and site of regional metastases are quite constant for every
single primary localisation and degree of histologic differentiation [119]. Important
factors related to the metastatic spread are the tumor size (partially function of time
since occurrence) and depth of infiltration [17,34,50]. Newer analyses point out, that
actually the tumor thickness rather than the tumor size (diameter or surface) is related to
the incidence of regional metastases [76,125]. In our VX2 model a little significant
correlation was found only between the maximal width of the tumor and the presence of
LN metastases (r=0.18 p=0.038). The other tumor dimension (maximal length,
thickness, base surface area) as well as the increase of all these dimensions from day 1
to day 9 do not seem to correlate with the presence of regional metastases.
The observed difference in the incidence of LN metastases between the CSR group
24.6% (16/65 animals) and the piecemeal LSR group 47.7% (31/65 animals) was found
statistically significant. This result was both surprising and disturbing. Our original
hypothesis was that there would be no difference in these two groups. This study raises
the question of whether tumor transection is responsible for this difference. If it is
assumed that the metastases in the CSR group are due only to the natural progression of
the cancer then the number of metastases above this level in the piecemeal LSR group
(15 of 65 or 23.1%) may be due to the tumor transection.
Having accepted this striking difference the most reasonable question seems to be
„Why?“ What mechanisms, what kind of interaction between the laser and the tumoral
tissue could precipitate metastatic spread?
5.3.1. Characteristics of the tumor microvasculature
An important background for possible explanations presents the anatomic
microstructure of the tumors and concretely the VX2 SCC. A tumor without blood
supply could not overgrow 200 mm because of the hypoxia [13]. It is the ability of
natural tumors to induce angiogenesis and for induced tumors complementary to use the
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local vessel network that plays a decisive local (for the tumor growth), regional (for
tumor spread) and systemic (paraneoplastic and immunological phenomena) role.
Tumors have the property to induce the growth of new blood vessels in many different
ways – physical factors (increased pressure), chemical factors (low pO2, low pH),
signal molecules (VEGF, angiopoietin). These new blood vessels are but structurally
and functionally abnormal. The endothelial layer is incompetent with tumoral cells
exposed [13,92]. Intratumoral vessels have diminished capacity to react to physical
stimuli, which could be explained again with the abnormal structure of their walls [19].
Only newly the absolute proangiogenic capabilities of tumors were questioned. Pezzella
et al reported on tumor growth based predominantly on existing normal blood vessels
without signs of neoangiogenesis [86].
The presence of intratumoral lymphatic vessels was earlier a quite debatable topic
[43,77]. The general opinion was that the tumors do not have lymphatics within, but
only enlarged peritumoral lymph vessels [13,54]. The most cancers are characterised by
high interstitial pressure in the centre, decreasing in the periphery and higher than in the
surrounding healthy tissue [44,77]. This again questions the presence of lymphatic
vessels within the tumours. Another opinion is that intratumoral lymphatic vessels exist,
but they are compressed and occluded by the proliferating tumor whereas at the
periphery excess VEGF-C causes lymphatics to enlarge [13].
Recent studies have proved, that tumors can induce lymphangiogenesis in the
surrounding tissue with resulting higher incidence of metastases [103]. In human SCC
lymphatic vessels have also been clearly proven and some lymphangiogenic properties
of the tumor were observed [6]. There are even opinions that SCC compared to other
cancer types is particularly active in stimulating lymphangiogenesis [43,77]. On their
side lymphatic vessels seem to be capable to actively attract tumor cell and lymphatic
metastases [121]. In some models based on xenotransplant tumors, intratumoral
lymphatic vessels have been detected. It is but not clear whether they arise in the tumor
or are just host lymphatics that become trapped in between the growing tumor foci
[47,108].
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The lymphatic system and its pathologic involvement differ between the different
animal groups and species. The human lymphatic system is predominantly
unidirectional – the lymph from a given peripheral region would be transported to the
central collector along relatively constant pathways. In the animal world the lymphatic
network is mostly multidirectional with large collaterals and anastomoses. This explains
the rare tendency of animals to suffer from lymphoedema compared with humans,
where drainage impairment along a lymphatic vessel leads to retrograde oedema [31].
Microvascular structure of the VX2 carcinoma
Experimental xenotransplant tumors comprise two blood networks: coopted vessels
from the preexisting network of the host vasculature and vessels resulting from the
angiogenic response of host vessels to cancer. In terms of angiogenesis the VX2 seems
to behave like the most xenotransplant tumors. Already at the first day after
transplantation the tumor induces neovascular growth. At the seventh day there is a
clear delineation between well perfused by the new vessels periphery and the already
partially avascular and necrotic centre [62,124]. The peripheral vascularisation exceeds
far that of the surrounding normal tissues and the avascular centre [39,88]. The VX2
tumor induces changes in the interstitial diffusion coefficients and the microvascular
permeability [45]. The acidity in the tumor interstitium is increased with a lower spatial
pH gradient away from the vessels [65]. This on its turn may influence the intratumoral
blood flow by changing the blood viscosity [116]. The intratumoral vessels have an up
to 8-fold increased permeability for macromolecules [35,75]. Our clinicopathological
observations support part of these findings. We observed the gradient of the vasculature
and the tumor vitality from the centre to the periphery in all specimens studied –
primary tumor, recurrences, LN and lung metastases. In larger tumors with dominant
central necrosis the tumor was viable only around the few intratumoral vessel and the
periphery. It is but impossible to state whether these vessels were coopted old ones or
induced by the tumor. We also found lymphatic vessels both intra and peritumoral.
They were identified by the absence of erythrocytes, the monolayer walls of endothelial
cells, absence of musculature and an incomplete or lacking basal lamina. These
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lymphatics often contained tumor emboli. It was easy to identify lymphatic vessels in
the tumor periphery. Intratumoral lymphatics were seldom observed.
5.3.2. Possible mechanisms of laser-tumor interaction
On the basis of this short overview on the tumoral angiogenic and lymphangiogenic
properties and microcirculation in natural and transplanted tumors and particularly the
VX2 carcinoma and our own clinical and histological findings we can hypothesize two
mechanisms of laser-tumor interaction, which could probably explain the observed
higher incidence of LN metastases after piecemeal laser-surgical resection.
1. Dissemination through the opened lymphatics at the resection line
The major argument of many proponents of piecemeal laser resection has been that the
laser beam seals the lymphatics in this zone thus making such dissemination impossible
[67,104]. This assumption is based on studies reporting occlusion of lymphatics by the
laser beam [36,37]. Some animal experiments have supported this thesis [78,115,120].
Another potential causative factor - the locally produced vapour was shown incapable to
propulse particles or cells along the lymphatic network [38]. However, other studies
support the contrary thesis that only the blood vessel are occluded by the laser, where as
lymphatics remain open. Experimenting with CO2 laser on the skin lymphatics Schenk
and Ehrenberg found that lymphatics are more resistant to laser „sealing“ than blood
vessels and remain wide open [99]. Laser similarly to freezing destroys cells but is
relatively protective for the connective tissue matrix [59]. Fligny et al. observed some
„sealing“ capabilities of laser on transected neurons. Nevertheless they pointed out that
this effect remains debatable [29]. In a small patient group Frühling et al. found no
evidence that CO2 laser beam obliterates the lymphatic drainage of the surgical wound
[30]. If this is true then the laser-cut end of a lymphatic could present a gateway for
precipitated tumor dissemination.
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2. Dissemination through lymphatics away from the resection line
2a. Dissemination through the walls of the intratumoral lymphatics
Penetration of the tumor emboli trough openings in the walls of a lymph vessel is
another mechanism that actually corresponds to the natural (spontaneous) mechanism of
this process. The cross-section opening of a cut lymphatic vessel should present a
difficult target for the tumor emboli because of the lymphatic vessel’s small cross-
section. With some approximation the lymphatic vessel could be regarded as a cylinder
(Fig. 20). The surface of its luminal cross-section would be Scs = pr2. A segment with
length equal to only the half of the radius (b = Scs/2pr = pr2/2pr = r/2) has already the
same surface. The endothelial lining of the vessel wall is incompetent because of
biochemical alterations in the basement membrane [84,92]. In this way it presents
multiple „openings“ which have a cumulative surface exceeding many times a normal
vessel’s cross-section.
Figure 20. The cross-section of the vessel has a much smaller surface than its walls.
Penetration of tumor cells through intercellular or larger defects in the walls is another
potential mechanism for initialisation of metastases.
2b. Dissemination along the peritumoral lymphatics
This is another natural mechanism of propagation of the neoplastic disease from the
primary localisation to the regional LNs.
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Both mechanisms of spontaneous metastasing - through the walls of the intratumoral
lymphatics and along the peritumoral lymphatics could be non-specifically precipitated
by piecemeal LSR in one or more of the following ways:
- Pressure decrease. The tumor (Latin tumor, a swelling) is actually a compressing
mass. Due to its growth and the increased interstitial pressure, which is higher than in
the surrounding healthy tissue it could compress and partially obliterate the intratumoral
and peritumoral lymphatics [44,77]. The partial decompression after the transtumoral
laser incision may release these vessels, causing a flood of tumor emboli. When cutting
through the tumor with the laser we have often seen this potential „release of pressure“.
This is especially the case in tumors with necrotic and partially liquefied centres where
the incision causes expulsion of these cancer fragments.
- Changes in the permeability and the lymph/blood flow caused by the local heat. When
it meets tissue the beam energy of the laser is converted to heat in explosive manner
[2,18,36,83]. This is the physical mechanism of the laser cutting. The technical
developments of the last years provided the clinical practice with laser devices operated
in modes that dramatically reduce the locally produced heat. As a result of his
experiments Harenberg supposes that the locally produced vapour could not propulse
particles or cells along the lymphatic network [38]. In our experiment a CO2 laser with a
continuous wave mode and a 10 watt power settings was used, similar to clinical
practice in order to perform larger and deeper incisions. Clearly local heating occurs.
There is carbonization, liquefaction and a visible laser plume. Additionally, surrounding
tissues were warm on palpation. This warming will lead to an enlargement of the
lymphatics which is associated with a changed flow. So this mechanism appears
reasonable and could not be excluded.
- A further potential mechanism for tumor spread is the mechanical trauma to the tumor
mass itself. Massage – the basic treatment of many conditions with lymph stasis - could
probably precipitate metastases if performed directly or indirectly on a tumoral mass. In
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our experiment group, laser tumor resection was associated with a mechanical effect
(holding, pulling and stretching the ear near the tumor by hand during the resection).
The resection-associated mechanical impact on the tumor was smaller in the CSR
group. With this technique the tumor was hardly touched – with one cut of the scalpel
the distal part of the auricle was detached. Mechanically stimulated intraoperative tumor
spread seems to be less likely. Although the approach in the LSR group was maximally
atraumatic again without touching the tumor itself, the manual fixation of the auricle
presented a comparatively greater indirect mechanical stress. This is often the case in
the endoscopic laser surgery for larger tumors. Here in the process of the preparation
parts of the tumor are grasped with the instrument. Additionally, traction on the
specimen which is done with laser resection produces mechanical pressure. Already the
process of exposure of the operating field through the laryngoscope could
hypothetically cause pressure on the surrounding tissues with modification of the lymph
flow.
The above-described hypothetical mechanisms apply to our study model and could
probably explain the observed higher incidence of metastases after piecemeal LSR. The
laser-tissue interaction on the cutting edge is only one factor, which was in the centre of
past scientific discussions. The above-mentioned processes concerning the entering of
tumor cells into the lymphatics were mostly based on processes associated with pressure
or flow. Mechanical and thermal processes in the tumor and its periphery could
definitively not be neglected. They seem to be relevant to the actual conditions in the
everyday laser surgery as it is practically impossible to completely separate the cutting
effect of the laser from the mechanical impacts of the whole surgical intervention.
Further studies are needed to test these hypotheses. The possibility of explosion-like
tumor cell spread into the lymphatic network must be discussed, which would then be
dependent on the applied laser energy. Till then the old rule of the thumb applying for
any kind of oncologic surgery (open surgery, endoscopic cold steel or laser) – minimal
contact trauma on the tumor – should be obeyed.
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5.4. Distant metastases
Distant metastases were found only in the lungs. In no case macroscopic metastases to
the trachea, liver or peritoneum were found. This corresponds to other reports, in which
only pulmonary metastases were found and only one single case of a tracheal metastasis
[111]. In the same article van Es describes another single case of a skip metastasis from
the primary tumor to the lungs at day 10 after implantation. In our group we found no
skip metastases. All animals with pulmonary involvement had nodal disease too.
The relationships between the incidence and characteristics of the lung metastases and
some clinical and pathological factors were analysed with Pearson product moment
correlation coefficient [69]. The presence of distant metastases correlated significantly
with the local recurrences (r=0.41 p<0.001), with the involvement of the first echelon
LN (r=0.48 p<0.001) and further nodal involvement (r=0.38 p<0.001). In order to check
which of these factors could be the main indicator for distant metastases partial
correlation and linear regression analysis were performed. After controlling for any one
or combination of these variables again all were found to correlate with pulmonary
involvement. This means that in our experimental setting both the local control (R0
resection) and the regional involvement appear equally important factors for distant
tumoral spread. On the other hand distant metastases seem not to be related to the tumor
growth speed and maximal size, the presence of necrotic changes in the tumor, the
presence of tumoral bleeding in advanced disease, the count and the maximal size of the
LN metastases. These finding correspond to the results of other investigators [111]. No
significant correlation of lung disease was found for the surgical technique (piecemeal
LSR or en bloc CSR) or for the intraoperative bleeding.
Apart of the general incidence the other parameters of the distant metastases - count of
pulmonary seedings, largest diameter, type of distribution (A, B, C – see page 36) were
analysed for the same clinical and pathologic factors. Statistically significant high
correlation was found for the number of pulmonary metastases and the resection
technique (r=0.79 p<0.001) but not for intraoperative bleeding. The number of
pulmonary foci was not related to the tumor size, growth, the count and size of LN
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metastases. No relationships between the diameter and/or the type of lung metastases
with any clinical or pathological factor was found.
The correlation between the presence of lung metastases and bad prognosis (early death)
was moderate (r=0.55 p<0.001). Only 9/19 (47.4%) of the animals with lung metastases
survived till the 51-st day. There was a very high negative relationship between the
number of pulmonary metastases and survival (r=-0.92 p<0.001).
Two mechanisms for distant tumor seeding have been discussed for the VX2 SCC in
NSW rabbit model. The one is the natural propagation of the disease from the primary
tumor or the neck metastases via the circulation. The other one is immediate
transvascular seeding already at the moment of tumoral injection. Here small portions of
the cell suspension could enter directly the blood vessels and build the early lung
metastases as well lymph node metastases [32]. This mechanism is characteristic for the
models of parenchymal injection of the cell suspension [66,111]. In intramuscular and
subcutaneous injection there is no evidence for such dissemination [111]. To evaluate
this hypothesis we analysed the incidence of distant metastases with the occurrence of
bleeding at the point of injection of the tumoral cell suspension. Such a bleeding is a
sign of injury to minor vessels, which could be a gate for direct haematogenous
dissemination. We observed bleeding during the injection in 6 animals (1 from the CSR
and 5 from the LSR groups). No one of these 6 animals presented afterwards distant
metastases. On this base we could state, that occasional direct intravenous injection is
unlikely to induce metastases.
Similar analysis showed that bleeding as a sign of trauma at the place of injection is not
related to local recurrences or metastases to the LNs.
Weight loss appears to be strongly associated with the presence of lung metastases, a
phenomenon also observed in humans. For the VX2 model van Es reported a significant
correlation between weight loss and primary tumour-size and between weight loss and
size of lung metastases [111]. In our study cohort the animals free of pulmonary
metastases gained weight (21.4±15.3% from the body mass at resection), whereas the
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animals with pulmonary involvement lost weight (-1.4±13.3%). Weight loss after the
3-rd postoperative week was a significant predictor for the presence of lung metastases
(p<0.01).
Without doubt the distant lung metastases are a sign of haematogenous dissemination.
Their clinical and pathological incidence is lower than that of lymphogenic metastases,
but this does not mean that the primary SCC „releases“ less tumoral cells in the blood
circulation than along the lymphatic collectors. We could speculate that actually the
lymphatic metastases present only the top of the iceberg of the total tumoral
dissemination. The phenomenon of a metastasis is a result of many complex factors
including release of tumoral cells/emboli from the primary (intravasation),
characteristics of the transport medium (blood/lymph) and vessels,
microangioarchitecture (lymphatic sinuses in the LNs; capillaries in the lungs) and
metabolism of the host organ [3,81,85]. In histologic sections from the primary tumor
we detected metastatic emboli both in the lymph and blood vessels. Predominantly the
lymphatics were involved and only occasionally the blood circulation. But this
difference could be an artefact – the blood net flow is about two to three orders of
magnitude higher than the flow rate of the lymph [108]. The tumor cells are just swept
away - we see the arch, but not the flying arrow. On the contrary - the clearance of the
tumoral cells in the lymphatics is lower and so they are often found on the histologic
slides. The composition of lymph is similar to that of interstitial fluid – the milieu from
witch the cells actually come. In contrast the blood is a concentrate of soluble active
macromolecules and cells that counteract the circulating metastases. Tumor emboli here
would experience serum and cell toxicity and high mechanical stress [8,108]. It is
estimated that only 1% of the circulating blood metastases could survive and
extravasate at the distant site where again only a small proportion would grow [51,84].
The regional LNs present a net where metabolic, cellular and last but not least
mechanical factors offer a „better“ milieu for the tumor cells.
With the background of the observed increased lymphogenic metastatic spread after
piecemeal LSR compared to en bloc CSR one might expect a higher incidence of
haematogenous (distant) metastases as well. In our experiment this incidence was
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similar for the both treatment groups - 8/65 (12.3%) for the CSR and 5/65 (7.7%) for
the piecemeal LSR. This low incidence could be due to ligation of the main auricular
artery at the beginning of the resection. This likely influenced the intra and peritumoral
circulation. In spite of this, however after this manipulation the operating field was far
from being dry. There was always bleeding over the resection line from collateral
vessels, which had to be coagulated or compressed by the skin sutures. The CO2 laser
provided much better haemostasis in the operating field. The bleeding was relatively
less. If bleeding from larger vessels occurred the beam was reapplied over them but
from an increased instance – the handpiece was pulled about 1 cm away from its
optimal working distance. In this way the beam was defocused, which resulted in
increase of its coagulating properties and minimisation of the sharp cutting effect. This
technique was effective for achieving complete haemostasis in 60/69 (87%) resections.
Only in 9/69 animals monopolar coagulation of sutures were necessary for controlling
the bleeding. This is another possible explanation for the observed similarity of the
haematogenous distant metastases between the groups. As it was already mentioned
there is no uniform opinion if the leaser occludes the lymphatics
[30,36,37,59,78,99,115]. On the contrary all of these authors agree that the CO2 laser
closes smaller blood vessels. Our results could be regarded as an experimental proof for
these morphological observations.
5.5. The CO2 laser in the otorhinolaryngologic surgery
In the last three decades the CO2 laser became the working horse in the field of
otorhinolaryngology. This is only one member of the large family of different laser
types based on different lasing materials (gases, solid state substances, organic dyes).
Soon after the discovery of the principle of LASER (light amplification by stimulated
emission of radiation) by Maiman in 1960 the exploration for possible applications of
this new tool started. Already at the beginning the medical researchers played an
important role. The first two laser types used in oncologic experimental setting - ruby
and Nd-in-glass achieved quite disappointing results – their mainly thermal effect
caused viable cancer cells to be propelled in the organism. 1965 devices emitting a
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focused CO2 laser beam were developed. The advantages of this new type of laser were
recognised soon after – it allowed not only for tissue destruction by evaporation, but for
extremely precise and bloodless cutting [102]. Strong and Jako were the first to
introduce the CO2 laser into microsurgery of the larynx in the early 1970s. Initially used
for resection of benign conditions the laser soon proved its advantages for the oncologic
surgery too [118]. The endoscopic laser surgical resection of early stage glottic
carcinomas has the advantage of very good oncologic results with minimal trauma to
the healthy tissues of this highly specialised organ. The phonatory function is preserved
in an optimal way [16,41,93]. Small malignancies of the epiglottis are easily extirpated
again with minimal lost of function [15,28]. In general for laryngeal neoplasms the
endoscopically visible mucosal part is predictable for the direction and extent of the
deep infiltration, as well for the infiltration of the cartilages of the framework [11]. The
classical surgical approach to malignancies of the upper aerodigestive tract comprises
well-established open surgical procedures, which follow well-defined resection lines –
predefined blocks are removed. Even by minimal tumoral invasion of a certain area the
whole block should be resected. On the contrary – the extent of the laser surgical
resection comprises only the tumor and a minimal healthy tissue around it. The
endoscopic microscopic laser surgery allows tailored resections, containing only the
actual tumor volume with the appropriate healthy margins, allowing for maximal
preservation of the skeleton of the organ, and respectively better functional results
[2,127]. The unique properties of a CO2 laser coupled to a surgical microscope allow for
extremely fine preparation of small hypopharyngeal carcinomas, which usually extend
over a considerable surface by a limited depth of infiltration [24,96,105]. After laser
surgical resection the wound should not be covered by mucosal or other flaps.
Postoperative irradiation could be started early after the resection, despite the
observation that laser wounds heal slower [59]. The carbonisation area at the resection
line is thin and allows the pathologist to judge, if the resection is in sano.
In the beginning the indications for laser tumoral resection in the upper aerodigestive
tract were limited to small tumors with clearly identifiable margins [12,107]. In
advanced tumoral disease laser was seen only as a palliative temporary measure for
tumor debulking [52,67,93]. Later with increasing experience of the surgeons and the
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technical improvements of the laser systems the extent of the endoscopic resections
increased. It is often the case, that larger tumors could not be well exposed through the
surgical laryngoscope. In order to resect them they have to be divided with the
CO2 laser in several parts, which are excised separately [15,106]. Using this technique
the surgeon could see under the microscope the depth of tumoral growth at the resection
line [2,95].
At first glance it could appear strange, that to cut through the tumor became so widely
accepted. Dividing the tumor with the laser seems opposed to the classical approach of
the oncologic surgery – resection as a whole block with the safety margins around and
even together with the regional LN groups. Particular laser-specific adverse effects have
also been described. The vapour produced locally under the laser beam could transfer
infectious material [33]. Tumor cells have been detected in laser plume. Though some
seemed morphologicaly intact they showed no viability signs and could not induce
tumor growth [79]. The idea to cut the tumor into pieces with the laser is a consequence
of the history of its clinical applications. The first laser systems were used to cause
tumor destruction in advanced disease. Only later the “cutting“ properties of the
CO2 laser were discovered. Today cutting through the tumor in the context of palliative
tumor debulking is widely accepted in the routine clinical practice [94].
The concept of tumor transection to include “piecemeal” resection is not limited to head
and neck C Î2  laser surgery only. This has been done with other surgical techniques and
other tools as well. If we have a vague glance at the history of the oncologic surgery we
will see that impairing the integrity of a tumor is a part of the usual oncologic practice,
especially concerning the head and neck tumors. Manipulation of a tumor including
incising it or partial resection is performed both with diagnostic and therapeutic intent.
Biopsy for histological verification is such an intervention. Mohs’ chemosurgery, or
even skull base resections, are other examples [7,25,74,80]. There is not any significant
medical literature to suggest regional or distant metastasis is higher in these groups. At
least since the Virchow‘s époque (second half of the 18th century) taking a biopsy for
histological examination before attempting treatment had became a standard [4]. Then
the biopsy was necessary to differentiate between cancer, tuberculosis, lues and other
55
benign conditions [26]. Nowadays not taking a biopsy is regarded as medical
malpractice. In cases with HNSCC this is the second most often allegation that leads to
suits after the failure to diagnose [60,61]. On the other hand lately in the literature
appeared reports, which prove that cutting the tumor for example for incisional biopsy
of HNSCC could cause haematogenous spread [51,81].
Piecemeal resection of laryngeal tumors with curative intent was one of the earliest
interventions carried out routinely after the newly introduced indirect laryngoscopy
gave the surgeon the possibility to see the larynx in the 60-ties of the 18-th century. At
that time this was performed with cold steel instruments or with electrocautery. A
„victim“ of this approach became the Prince Frederick of Prussia. In 1887 he presented
with hoarseness, which was resistant to conservative therapy. The examination revealed
laryngeal tumoral mass. The clinical diagnosis of carcinoma of the left vocal fold was
quite obvious. The several attempts to resect the tumor with minimally invasive
galvanocautery performed by C. Gerhard – outstanding professor of internal medicine
from the University of Berlin – led to postponing of the radical surgical treatment and
obvious propagation of the local disease in this 56-years old VIP patient [26]. Piecemeal
resection of laryngeal tumors with an electrocautery had its proponents till the second
half of the 20-th century [49].
Piecemeal resection of HNSCC with palliative intent is another widely accepted
approach in patients with advanced disease. Here the objective is debulking the tumor
mass in order to enlarge the lumen of the involved organ and provide better quality of
life for the patient. The intervention is used in incurable disease to improve the
respiratory and/or alimentary status of the patients with cancer of the larynx, trachea,
large bronchi, hypopharynx and oesophagus [1,15,94].
Partial laser-surgical tumor resection as a temporary measure for relief of dyspnea
before definitive treatment is an accepted alternative to tracheotomy in patients with
advanced laryngeal cancer. Laser tumor mass reduction for obstructing laryngeal
tumors, followed by other definitive treatment does not lead to stomal recurrences [67]
as known with tracheostomy in interval before laryngectomy [72].
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As we could see from this short overview the piecemeal resection of malignancies of the
upper aero-digestive tract precedes the apparition of the surgical lasers. This approach
has been but rarely analysed in the concrete light of perioperative tumoral
dissemination. In the past the main therapeutic aim of the surgery has been the complete
removal of the tumoral mass. The current concept yet remains that the goal of the
surgery is again complete removal of the tumor mass. This has its clinical rationale. In
our experiment we also observed, that the presence of residual tumor at the primary
localisation is one of the most strong bad prognostic factors. Only lately there is an
important concern about the iatrogenic potentiation of the metastatic spread, both
regional and distant. This coincides with the introduction of the laser surgical systems.
Whereas current purely clinical studies do not suggest any increased metastatic rates
due to tumor transection before total removal in the CO2 laser endoscopic cancer
treatment model, our study does raise some concern [15,67,94,106]. The lack of
reported increased metastases could be explained with the preselection of the patients
for laser surgery, and even more importantly, with the fact, that most of the patients
subjected to laser resection were also treated by neck dissection and/or postoperative
irradiation. In advanced cancer regional treatment is a compulsory step, as the majority
of patients already have at presentation clinical or occult neck disease. This therapy to
the neck could mask a hypothetical increase of the lymphogenic metastasing after
piecemeal laser surgical resection. If this is indeed true, then postoperative irradiation in
tumors large enough to require endoscopic transection versus endoscopic en bloc
resection is indeed reasonable.
We recognize that there was a difference in the width of the resection margin between
the en bloc and tumor transection models. This was intentionally chosen so as to be
analogous to partial versus total laryngectomy in patients. This difference in resection
margin itself could explain the difference in the extent of regional metastasis if it is
assumed that “in-transit” tumor spread beyond the narrow margin of the laser resected
animals occurred, but was yet within the margin of tissue removed with en bloc
resection. This is an important consideration, as partial laryngeal surgery, especially in
the glottic larynx, will by definition not have wide margins. It is an interesting
hypothetical question whether perioperative chemotherapy, or even postoperative
irradiation would destroy these “in-transit” tumor cells. It is further interesting to
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speculate whether staged or delayed neck dissection would have lowered the metastastic
rate in the “piecemeal” surgical group. Further animal studies could address this issue.
While the stimulus in doing this study was our interest in transoral CO2 laser surgery,
the study actually has relevance to any CO2 laser surgical approval where “piecemeal”
resection has been or could be used (eg. rectal, uterine, or esophageal surgery). These
concepts of en bloc versus “piecemeal” resection together with questions regarding the
use of chemotherapy and/or irradiation with this type of surgery will become even more
important as minimally invasive surgery techniques are further developed.
5.6. New considerations on the VX2 auricle SCC model
5.6.1. Hematogenic metastases
It was a generally accepted opinion, that the VX2 auricle model gives predominantly
lymphatic metastases [21,23,111]. Now we have morphologic evidence, that the
primary tumor could give direct hematogenic metastases (Fig. 8, page 68). This finding
did not affect the clinical and end pathological result, which corresponded to the
established concepts. We did not observe any cases of skip metastases from the primary
to the lungs. The distant metastases appear to follow the initial lymphogenic ones. All
this supposes the presence of minimal or may be even massive process of intravasation
of tumor emboli at the primary tumor, which remains but hidden for the study models
implemented by now, because of its high speed and low take-rate in the periphery.
Nevertheless this aspect requires further investigations. If such increased haematogenic
dissemination with subclinicaly low take rate really exists a similar process could be
suspected for SCC in humans as well [51,84].
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5.6.2. Parotideal lymph nodes
Another generally accepted opinion was that there is only one LN in the parotideal
region [21,23,111]. In some older reference books on the rabbit anatomy this LN is even
missing, whereas the other LN groups along the neck are presented in details [87]. Of
the 139 animals included in our study in 15 (10.8%) an evidence of a second LN in this
region was found. Five of them had 2 separate macrsocopic metastases. Actually they
lied closely to each other and presented as one spheroid. There was but a clear
equatorial line in the thick fibrous capsule surrounding this complex. Dissection along
this line showed that there are actually 2 distinct metastases. Unfortunately the
advanced tumoral and necrotic changes did not allow to histologically find traces of the
pretumoral architecture of these LN. In one case an intact LN was found aside to a large
necrotic metastasis in the parotideal region (Fig. 15b, page 72). These observations
suggest possible metastasing directly into the paroideal parenchyma. Such a mechanism
could not be excluded, having in mind the characteristic absence of
compartimentalisation between the epithelial and mesenchymal (including lymphoid
tissue) components in the early stages in their development. As a result from such an
embryologic development the parotis and its lymph nodes represent a particular
complex [63]. The variability in the number of the parotideal LNs that we observed,
corresponds better to the notion of varying number of LNs in the parotideal gland of
humans [109]. The parotid gland is the only salivary gland to contain LNs. This
anatomical premise and the characteristic gland/lymph node symbiosis explains the
frequency of head and neck metastases to the parotis [5]. These LNs are a common
place for metastases from the skin of the head and face. In our experimental model the
VX2 tumor is induced on the auricle, and similarly to humans spreads to the parotideal
region.
5.6.3. Technique of tumor injection
In our study cohort we achieved successful transplantation in 99.3% of the animals.
This figure differs significantly from the results reported in the literature – 78%-83%
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[21,22,111]. This is partially due to the improved inoculation technique – a factor,
which has been evaluated and found quite important by other studies [111]. We found
the technique of tumor transplantation in previously prepared by gas décollement
subcutaneous pocket very useful. It allowed injecting the cell suspension with ease at
considerably lower pressures compared to the direct injection. This reduced the lost of
cell suspension volume. On the other hand injecting at lower pressure causes less
mechanical stress to the tumoral cells, so the number of viable ones does not decrease.
The technique resulted as well into a better hygiene at the targeted area.
The technique of injection determines to some extent the tumor size. As the needle is
introduced through the subcutaneous plane it forms a channel. During the withdrawal
this channel gets contaminated with tumoral cells, which give rise to complementary
tumoral growth. In this way the length of this channel could add to the longitudinal
diameter of the initial tumor. As a results further calculated values (base surface –
ellipsoid, tumor volume – half spheroid) are perturbed.
Other possible explanation for the good take rate in our experiment includes the early
time of the resection – 8 days after the inoculation. Spontaneous regression of the VX2
SCC in rabbits has been described, but at relatively later time points – after the 21 day
[111]. Nevertheless in our experimental setting the differentiation between „takes“ and
„non-takes“ was clear. In all but one animal the tumor mass had increased its
dimensions by the time of resection and the tumoral masses had a vital aspect, that was
consecutively proven histologically. The only case of an animal with shrinkage of the
tumor and atypical macroscopic aspect (to small, pale, hard, resembling a scar) was
excluded from the analysis. In this case the histological examination showed small nests
of absolutely vital proliferating tumor that probably would have grown with the time.
An argument in favour of this prognosis present the few cases we have observed in
another experiment, where atypically late tumor reappearance and growth occurred in
animal, considered by as „non-takers“. In these animals the tumor reappeared about 14
days after it was considered for a „non-take“ or regression.
Originally the VX2 was derived from the V1 SCC cell line by multiple passages during
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which the take rate in the late generations increased [48]. Such a shift in the properties
of our VX2 line compared to those of the original one obtained from Prof. Dr. Robert
J.J. van Es (Department of Oral and Maxillofacial Surgery, University Medical Center
Utrecht, Utrecht, Niederlande) could not be excluded [111].
5.6.4. Technical note on the animal handling.
As mentioned earlier 3 animals were lost as a result of peri- and postoperative
complications. One died during the operation, probably of anaesthesia overdosage. One
animal was found dead in the transporting case after successful operation. The transport
from the operating theatre to the cages lasts about 2-3 minutes. The third animal was
found dead in the cage after successful operation. Initially all these cases were attributed
to anaesthesia overdosage. Later in similar situations we observed that in certain body
positions the anaesthetised animal could compress and occlude its nose so it could not
breathe. In several further animals we tried temporary manual obstruction of the nose
with the animal already under anaesthesia with the usual combination 5mg/kg
xylazinhydrochlorid and 100mg/kg ketaminhydrochlorid The animals could again not
breathe and were unable to change the body position. It appears that the compression of
the nose could lead to suffocation. Even though that the transporting box and the cages
were specially constructed with the appropriate openings there are dangerous corners,
where the animal‘s nose could get occluded.
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6. Conclusion
The aim of the present study was to compare the piecemeal laser surgical (R0) resection
with cold steel (R0) resection en bloc. For this purpose the auricle VX2 squamous cell
carcinoma model in New Zealand White rabbits was used. The major study parameter
that were to be evaluated included the incidence of tumoral recurrences (local control),
incidence and distribution of regional lymphatic metastases and the incidence of distant
visceral metastases.
In this concrete experimental setting both surgical techniques achieved comparable local
control. The laser-surgical resection resulted in preservation of a larger amount of
healthy tissues and structures. The piecemeal laser-surgical resection lead to more
regional lymphatic metastases than the cold steal en bloc resection (47.7% vs. 24.6%).
This difference was found statistically significant. However, it is not possible to state
that tumor cells disseminated from the resection line itself caused this difference or it
was due to malignant cell dissemination from deeper tumoral and peritumoral layers.
The incidence of distant pulmonary metastases was comparable for the both groups with
minor differences, which did not prove to be significant in the observed small group.
The presence of local recurrence showed to be a decisive factor for both lymphatic and
haematogenous metastatic spread and the overall prognosis.
It is quite probable, that piecemeal laser surgical resection of HNSCC in humans is also
associated with increase in lymphatic metastases. The designs of the reported in the
literature morphological and clinical studies have been insensitive to answer this
specific question. The morphological data on „sealed lymphatics“ is controversial. In
the clinical trials preselected patients were included and adjuvant therapy for the
regional disease (neck dissection and/or radiotherapy) has been performed. Piecemeal
resection has been the approach mainly in advanced tumoral disease. In such cases
involvement of the regional LN was usually present or assumed and required therapy.
62
Our experimental result and the clinical experience underline the need for elective
treatment of the neck after piecemeal laser-surgical resection of extended HNSCC.
Cutting through the tumor when not necessary just to see the depth of infiltration could
be hazardous.
In this experiment it was impossible to distinguish between the role of the laser itself
and the concomitant mechanical impact associated with the surgery as the factors
leading to lymphatic metastases. In the endoscopic laser surgery these two factors are
again difficult to separate. Further studies should address the question for the
cost/benefit ratio of laser resection of large tumors en bloc (with more mechanical
manipulation of the resectat) compared to piecemeal laser surgical resection (as a
measure to minimize the mechanical trauma during the dissection and extirpation). This
study will lead to a renewed investigation of whether tumor transection leads to
increased metastasis with laser surgery, and further what interventions are possible to
alter or eliminate the phenomenon. The role of perioperative chemotherapy,
postoperative irradiation, or even staged neck dissection can, and should be
investigated.
Deeper knowledge of the tool LASER would not change its essence, but will allow us to
use it in a better way. For the good of the patient.
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Appendix
Figure 2: Tumor induction. a) VX2 SCC in the gluteal musculature 14 days after
induction; b) Trypan blue staining of the cells in the suspension. Live cells exclude the
blue dye, and appear clear. Dead cells take up the dye and appear blue;
c) Subcutaneous inoculation of 0.3 cc tumor cell suspension.
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Figure 3: Tumor growth. a) Measurement of the tumor 4 days after inoculation;
Different macroscopic aspects of the VX2 tumor at the 8-th day after the induction:
b) No necrosis, bleeding grade 1; c) Necrosis grade 2.
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Figure 4: Conventional cold steel resection (CSR) of the tumor. a) The resection line
goes through macroscopically healthy tissue 1.5-2.5 cm away from the visible tumor
border. Complete ablation of the distal part of the auricle is performed; b) The wound
is covered by small skin flaps meticulously sutured without perforating the cartilage.
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Figure 5: Piecemeal laser-surgical resection (LSR) of the tumor. a) The resection is
performed with 10 W in continuous wave mode; b) The first cut goes through the tumor;
c) The proximal aspect of the cutting surface with minor bleeding and carbonisation
traces. In the centre is a small necrotic area (arrow); d) The second cut goes through
macroscopically healthy tissue 0.5 cm away from the visible tumor border.
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Figure 6: Topography of the lateral neck of the NSW rabbit. 1) parotideal LN with a
large metastasis. 2) enlarged caudal LNs under the fascia at the bifurcation of the
external jugular vein (ejv). The rostral mandibular LNs 3) are usually located at the
bifurcation of the linguofacial vein (lfv). mv - mandibular vein; cav - caudal auricle
vein.
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Figure 8: a) General aspect of the primary tumor (H&E x5). In detail another
lymphatic metastasis (H&E x50). ; b) Periphery of the tumor with 3 metastatic emboli
in lymphatic vessels (arrows) Note the necrotic changes towards the tumor’s centre
(H&E x5); c) Microscopic aspect of the tumor cells (H&E x100); d) A rare finding -
metastatic embolus in a blood vessel in the tumor’s periphery. (H&E x50). Are
haematogenous metastases really that rare?
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Figure 9: Histologic characteristics of the resection line. a) A cut with scalpel
(H&E x25). b) Laser cut through healthy tissue. The wound is sealed by a coagulation
zone (H&E x25). c) Cut with laser through the tumor (H&E x50). d) In areas with
tumor necrosis the coagulated layer is thinner and could be easily detached.
(H&E x100).
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Figure 10: Macroscopic aspects of the wound after laser surgical resection. a) Wound
healing at days 3, 7, 10 and 12; b) Fibrous scar on the curve between the transversal
and longitudinal parts of the resection line. During maturation it contracts and causes a
deformation of the auricle.
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Figure 14: a) A LN form the parotideal region with normal structure (H&E x25).
b) Large LN metastasis with thickened fibrous capsule, peripheral and perivascular
vital tumor and necrosis towards the centre (H&E x50). c) Enlarged (27x19 mm)
activated LN without tumoral involvement (H&E x25). d) Enlarged LN with foamy
macrophages. Again no tumoral involvement is present (H&E x25).
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Figure 15: a) Two metastases in the parotideal region. b) A tumoral mass in the
parotideal region with large central necrosis and active cancer cells only in the
periphery (H&E x5). Note the intact LN on its side. The finding suggests the presence of
more than one LN in this region or direct metastases to the parotideal gland. The
advanced necrosis did not allow to identify in what kind of initial structure (LN or
gland) the metastasis developed;
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Figure 20: Macroscopic aspect of the lung metastases. a) Single metastasis type A;
b) Multiple metastases type B; c) Multiple metastases type C.
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Figure 22: Histologic aspect of the lung metastases. a) Small central VX2 metastasis;
b) The large metastases show typical concentric layers. The centre is necrotic, full with
leucocytes. Live active tumoral cells are to be observed only in the periphery or around
small blood vessels (arrow). The tumor periphery is well delineated by a pseudocapsule
of compressed parenchyma without fibrosis; c) Multiple lung metastases. Note the
compressed parenchyma between them.
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